Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction

Schizophrenia Research

Volumn 86, Issue 1-3, 2006, Pages 284-290

  Dubertret, Caroline ^a,b   Bidard, Isabelle ^b   Adès, Jean ^a,b   Gorwood, Philip ^a,b  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Cannabis abuse and dependence; Psychotic symptoms; Schizophrenia

Indexed keywords

CANNABIS;

ADULT; APATHY; ARTICLE; CANNABIS ADDICTION; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HALLUCINATION; HUMAN; INCIDENCE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; DELUSIONS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HALLUCINATIONS; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 33747158235     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.05.006     Document Type: Article

References (24)

1. Addington J., and Addington D. Effect of substance misuse in early psychosis. Br. J. Psychiatry 172 (1998) 134-136
2. Arseneault L., Cannon M., Witton J., and Murray R.M. Causal association between cannabis and psychosis. Examination of the evidence. Br. J. Psychiatry 184 (2004) 110-117
3. Bersani G., Orlandi V., Kotzalidis G.D., and Pancheri P. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. Eur. Arch. Psychiatry Clin. Neurosci. 252 (2002) 86-92
4. Brunette M.F., Mueser K.T., Xie H., and Drake R.E. Relationships between symptoms of schizophrenia and substance abuse. J. of Nerv. Ment. Dis. 185 (1997) 13-20
5. Bühler B., Hambrecht M., Loffler W., an der Heiden W., and Hafner H. Precipitation and determination of the onset and course of schizophrenia by substance abuse - a retrospective and prospective study of 232 population-based first illness episodes. Schizophr. Res. 54 (2002) 243-251
6. Caspari D. Cannabis and schizophrenia: results of a follow-up study. Eur. Arch. Psychiatry Clin. Neurosci. 249 (1999) 45-49
7. Cleghorn J.M., Kaplan R.D., Szechtman B., Szechtman H., Brown G.M., and Franco S. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J. Clin. Psychiatry 52 (1991) 26-30
8. Compton M.T., Furman A.C., and Kaslow N.J. Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample. Schizophr. Res. 71 (2004) 61-64
9. Dixon L., Haas G., Weiden P.J., Sweeney J., and Frances A.J. RDrug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry 148 (1991) 224-230
10. D'Souza D.C., Abi-Saab W.M., Madonick S., Forselius-Bielen K., Doersch A., Braley G., Gueorguieva R., Cooper T.B., and Krystal J.H. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol. Psychiatry 57 (2005) 594-608
11. Fenton W.S., Blyler C.R., and Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr. Bull. 23 (1997) 637-651
12. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., and van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330 7481 (2005) 11
13. Hosmer D.W., and Lemeshow S. Applied Logistic Regression (1989), Ed. John Wiley and Son, New York
14. Kendler K.S., Gallagher T.J., Abelson M.J., and Kessler R.C. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch. Gen. Psychiatry 53 (1996) 1022-1031
15. Kirkpatrick B., Amador X.F., Flaum M., Yale S.A., Gorman J.M., Carpenter Jr. W.T., Tohen M., and McGlashan T. Deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse. Schizophr. Res. 20 (1996) 69-77
16. Linszen D.H., Dingemans P.M., and Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch. Gen. Psychiatry 51 (1994) 273-279
17. Margolese H.C., Malchy L., Negrete J.C., Tempier R., and Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr. Res. 67 (2004) 157-166
18. Martin G., Copeland J., Gates P., and Gilmour S.R. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. Drug Alcohol Depend. 83 (2006) 90-93
19. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., and Teich T. Diagnostic Interview for Genetic Studies: rational, unique features, and training. Arch. Gen. Psychiatry 51 (1994) 849-862
20. Peralta V., and Cuesta M.J. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr. Scand. 85 (1992) 127-130
21. Pulver A.E., Wolyniec P.S., Wagner M.G., Moorman C.C., and McGrath J.A. An epidemiologic investigation of alcohol-dependent schizophrenics. Acta Psychiatr. Scand. 79 (1989) 603-612
22. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., and Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264 (1990) 2511-2518
23. Salyers M.P., and Mueser K.T. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr. Res. 48 (2001) 109-123
24. Sorbara F., Liraud F., Assens F., Abalan F., and Verdoux H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur. Psychiatr. 18 (2003) 133-136